Ingredion to Report Q1 Earnings Amid Expected Revenue Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 29 2026
0mins
Source: seekingalpha
Ingredion Inc (INGR) is down 3.03% and has hit a 20-day low amid broader market weakness, with the Nasdaq-100 and S&P 500 both declining.
The company is set to announce its Q1 2023 earnings on May 5, with a consensus EPS estimate of $2.47, reflecting a 16.8% year-over-year decline. Additionally, anticipated revenue of $1.79 billion represents a 1.1% year-over-year decrease, indicating ongoing challenges that could negatively impact investor sentiment. Furthermore, the recent appointment of Jason Payant as interim CFO may influence the company's financial strategy during this critical period.
These factors suggest that Ingredion is facing significant headwinds, which could affect its stock performance in the near term as investors react to the upcoming earnings report.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INGR
Wall Street analysts forecast INGR stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 100.810
Low
119.00
Averages
125.50
High
136.00
Current: 100.810
Low
119.00
Averages
125.50
High
136.00
About INGR
Ingredion Incorporated is a global ingredient solutions provider that transforms grains, fruits, vegetables and other plant-based materials into ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. The Company operates through three segments, which include Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients (F&II)–Latin America (LATAM), and F&II–U.S./Canada. The Texture & Healthful Solutions segment primarily manufactures texturizing food ingredients. The Food & Industrial Ingredients segment primarily manufactures food, ingredient, and industrial products, which are processed from raw materials that primarily source within South America and Mexico. The Food & Industrial Ingredients–United States/Canada segment primarily manufactures food, ingredients, and industrial products. The Company's Benicaros is a patented, prebiotic fiber made from upcycled carrot pomace clinically to support immune health.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stock Futures Rise as Market Sentiment Recovers
- Market Sentiment Recovery: After a significant drop on Friday, U.S. stock futures rose on Monday, with the S&P 500 gaining 0.30% despite the Dow Jones Industrial Average closing down 0.17%, indicating a slight improvement in investor sentiment.
- Rising Interest Rates Impact: The S&P 500 opened with its largest gap in eight weeks, but the rise in long-term Treasury yields, with the 30-year bond closing at 5.04%, weakened market support, preventing bulls from maintaining their initial gains.
- Oil Price Volatility: Global oil inventories continue to decline despite ceasefire efforts, with Brent crude closing at $94.22, up 1.21%, reflecting market expectations for rising oil prices that could influence investment decisions in related sectors.
- Cryptocurrency Market Recovery: Bitcoin rebounded to nearly $64,200 after shedding approximately $235 billion in market value, indicating market stabilization, although investor sentiment remains cautious, which may affect future investment flows.
See More
Tate & Lyle Acquired by Ingredion in £2.7 Billion Deal
- Acquisition Agreement: Tate & Lyle has reached an all-cash acquisition agreement with Ingredion at 595 pence per share, valuing the deal at approximately £2.7 billion ($3.6 billion), significantly enhancing Ingredion's position in the specialty ingredients market.
- Shareholder Gains: The transaction offers Tate & Lyle shareholders a 59% premium, with completion expected in the second half of 2027, further strengthening the company's competitiveness in the health food sector.
- Cost Savings Outlook: The acquisition is projected to deliver annual run-rate cost savings of $130 million by 2030, despite initial costs of about $175 million to achieve these savings, indicating long-term financial benefits.
- Clear Financing Structure: Ingredion plans to fund the deal through cash, new debt, and, if necessary, a bridge facility, expecting a net leverage ratio of 3.0 times at closing and aiming to reduce it to 2.5 times within 18 months, demonstrating financial robustness.
See More
Ingredion Acquires Tate & Lyle for £3.7 Billion
- Acquisition Overview: Ingredion Inc. announced an all-cash acquisition of British sweetener firm Tate & Lyle for £3.7 billion (approximately $5 billion), with a per-share price of 595 pence representing a 59% premium over its closing price on May 13.
- Positive Market Reaction: Shares of Tate & Lyle surged 13.25% on the London Stock Exchange to 556.50 pence, while Ingredion's shares rose 1.95% in pre-market trading on the NYSE to $101.93, indicating strong market confidence in the acquisition.
- Cost Savings Expectations: Ingredion anticipates achieving annual run-rate cost savings of $130 million by 2030, despite one-time costs of approximately $175 million to realize these savings, reflecting the company's confidence in operational efficiencies post-acquisition.
- Financial Arrangements and Outlook: The acquisition will be executed through a UK court-sanctioned scheme and is expected to close in the second half of 2027; Ingredion plans to reduce its net debt to adjusted EBITDA ratio from 3.0 to 2.5 post-transaction, demonstrating a commitment to financial stability.
See More
Tate & Lyle Agrees to £2.7 Billion Takeover by Ingredion
- Acquisition Agreement: Tate & Lyle has agreed to a £2.7 billion cash takeover by U.S.-based Ingredion, marking a significant new chapter for one of Britain's oldest industrial names and expected to enhance its position in the global food and beverage ingredients market.
- Historical Overview: Founded in the mid-19th century, Tate & Lyle has evolved from a sugar refining business to a focused food ingredients company through strategic acquisitions and restructuring, demonstrating its adaptability to market changes.
- Market Impact Analysis: This acquisition is poised to significantly increase Ingredion's market share in the global food ingredients sector, enhancing its competitiveness in the rapidly growing market for plant-based products and driving future revenue growth.
- Future Development Outlook: Upon completion of the acquisition, Tate & Lyle will leverage Ingredion's resources and network to accelerate innovation and development in health-focused foods and alternative sweeteners, aligning with current consumer trends towards healthier eating.
See More
Ingredion to Acquire Tate & Lyle for £3.7B
- Acquisition Scale: Ingredion has agreed to acquire Tate & Lyle PLC in an all-cash deal valued at approximately £3.7 billion ($5 billion), aiming to expand its portfolio of specialty ingredient solutions for food, beverage, and industrial markets, thereby enhancing its competitive edge.
- Cost Synergies: The integration is expected to deliver significant run-rate net cost synergies of approximately $130 million, which are anticipated to be fully realized by the end of 2030, significantly boosting Ingredion's profitability and operational efficiency.
- One-Time Cost Investment: To achieve these annual cost savings, one-time costs are expected to amount to approximately $175 million by the end of 2030, laying a solid foundation for future financial performance.
- Shareholder Earnings Outlook: The acquisition is expected to be accretive to Ingredion's earnings per share (EPS) in the first year post-transaction, further enhancing the long-term growth profile and earnings potential of the combined entity.
See More
Ingredion Acquires Tate & Lyle to Create Global Leader in Food Solutions
- Acquisition Scale: Ingredion's all-cash offer of approximately £3.7 billion ($5.0 billion) for Tate & Lyle significantly enhances its market position in the food and beverage sector, expected to create substantial value for shareholders.
- Strategic Synergies: The acquisition integrates expertise in mouthfeel, sweetening, and fortification, enhancing Ingredion's capabilities in multi-ingredient systems and recipe development, thereby better addressing customer demands for healthier, nutritious, and sustainable food products.
- Cost Synergies: The integration is projected to deliver approximately $130 million in annual net cost synergies, fully realized by the end of 2030, despite one-time costs of about $175 million, ultimately strengthening the company's profitability and growth potential.
- Market Expansion and Innovation: The acquisition significantly expands Ingredion's scale in North America, Europe, and emerging markets, leveraging both companies' technological and intellectual property strengths to drive innovation and accelerate new product launches, meeting evolving consumer needs.
See More
U.S. Stock Futures Rise as Market Sentiment Recovers
- Market Sentiment Recovery: After a significant drop on Friday, U.S. stock futures rose on Monday, with the S&P 500 gaining 0.30% despite the Dow Jones Industrial Average closing down 0.17%, indicating a slight improvement in investor sentiment.
- Rising Interest Rates Impact: The S&P 500 opened with its largest gap in eight weeks, but the rise in long-term Treasury yields, with the 30-year bond closing at 5.04%, weakened market support, preventing bulls from maintaining their initial gains.
- Oil Price Volatility: Global oil inventories continue to decline despite ceasefire efforts, with Brent crude closing at $94.22, up 1.21%, reflecting market expectations for rising oil prices that could influence investment decisions in related sectors.
- Cryptocurrency Market Recovery: Bitcoin rebounded to nearly $64,200 after shedding approximately $235 billion in market value, indicating market stabilization, although investor sentiment remains cautious, which may affect future investment flows.
See More
Tate & Lyle Acquired by Ingredion in £2.7 Billion Deal
- Acquisition Agreement: Tate & Lyle has reached an all-cash acquisition agreement with Ingredion at 595 pence per share, valuing the deal at approximately £2.7 billion ($3.6 billion), significantly enhancing Ingredion's position in the specialty ingredients market.
- Shareholder Gains: The transaction offers Tate & Lyle shareholders a 59% premium, with completion expected in the second half of 2027, further strengthening the company's competitiveness in the health food sector.
- Cost Savings Outlook: The acquisition is projected to deliver annual run-rate cost savings of $130 million by 2030, despite initial costs of about $175 million to achieve these savings, indicating long-term financial benefits.
- Clear Financing Structure: Ingredion plans to fund the deal through cash, new debt, and, if necessary, a bridge facility, expecting a net leverage ratio of 3.0 times at closing and aiming to reduce it to 2.5 times within 18 months, demonstrating financial robustness.
See More
Ingredion Acquires Tate & Lyle for £3.7 Billion
- Acquisition Overview: Ingredion Inc. announced an all-cash acquisition of British sweetener firm Tate & Lyle for £3.7 billion (approximately $5 billion), with a per-share price of 595 pence representing a 59% premium over its closing price on May 13.
- Positive Market Reaction: Shares of Tate & Lyle surged 13.25% on the London Stock Exchange to 556.50 pence, while Ingredion's shares rose 1.95% in pre-market trading on the NYSE to $101.93, indicating strong market confidence in the acquisition.
- Cost Savings Expectations: Ingredion anticipates achieving annual run-rate cost savings of $130 million by 2030, despite one-time costs of approximately $175 million to realize these savings, reflecting the company's confidence in operational efficiencies post-acquisition.
- Financial Arrangements and Outlook: The acquisition will be executed through a UK court-sanctioned scheme and is expected to close in the second half of 2027; Ingredion plans to reduce its net debt to adjusted EBITDA ratio from 3.0 to 2.5 post-transaction, demonstrating a commitment to financial stability.
See More
Tate & Lyle Agrees to £2.7 Billion Takeover by Ingredion
- Acquisition Agreement: Tate & Lyle has agreed to a £2.7 billion cash takeover by U.S.-based Ingredion, marking a significant new chapter for one of Britain's oldest industrial names and expected to enhance its position in the global food and beverage ingredients market.
- Historical Overview: Founded in the mid-19th century, Tate & Lyle has evolved from a sugar refining business to a focused food ingredients company through strategic acquisitions and restructuring, demonstrating its adaptability to market changes.
- Market Impact Analysis: This acquisition is poised to significantly increase Ingredion's market share in the global food ingredients sector, enhancing its competitiveness in the rapidly growing market for plant-based products and driving future revenue growth.
- Future Development Outlook: Upon completion of the acquisition, Tate & Lyle will leverage Ingredion's resources and network to accelerate innovation and development in health-focused foods and alternative sweeteners, aligning with current consumer trends towards healthier eating.
See More
Ingredion to Acquire Tate & Lyle for £3.7B
- Acquisition Scale: Ingredion has agreed to acquire Tate & Lyle PLC in an all-cash deal valued at approximately £3.7 billion ($5 billion), aiming to expand its portfolio of specialty ingredient solutions for food, beverage, and industrial markets, thereby enhancing its competitive edge.
- Cost Synergies: The integration is expected to deliver significant run-rate net cost synergies of approximately $130 million, which are anticipated to be fully realized by the end of 2030, significantly boosting Ingredion's profitability and operational efficiency.
- One-Time Cost Investment: To achieve these annual cost savings, one-time costs are expected to amount to approximately $175 million by the end of 2030, laying a solid foundation for future financial performance.
- Shareholder Earnings Outlook: The acquisition is expected to be accretive to Ingredion's earnings per share (EPS) in the first year post-transaction, further enhancing the long-term growth profile and earnings potential of the combined entity.
See More
Ingredion Acquires Tate & Lyle to Create Global Leader in Food Solutions
- Acquisition Scale: Ingredion's all-cash offer of approximately £3.7 billion ($5.0 billion) for Tate & Lyle significantly enhances its market position in the food and beverage sector, expected to create substantial value for shareholders.
- Strategic Synergies: The acquisition integrates expertise in mouthfeel, sweetening, and fortification, enhancing Ingredion's capabilities in multi-ingredient systems and recipe development, thereby better addressing customer demands for healthier, nutritious, and sustainable food products.
- Cost Synergies: The integration is projected to deliver approximately $130 million in annual net cost synergies, fully realized by the end of 2030, despite one-time costs of about $175 million, ultimately strengthening the company's profitability and growth potential.
- Market Expansion and Innovation: The acquisition significantly expands Ingredion's scale in North America, Europe, and emerging markets, leveraging both companies' technological and intellectual property strengths to drive innovation and accelerate new product launches, meeting evolving consumer needs.
See More
